Phacilitate Leaders World

Speakers

Loading
Louis  Juliano

Louis Juliano

Senior Vice President, Global Sales & Business Development, HemaCare Corporation

Louis Juliano has been a Senior Vice President with HemaCare since joining the company in July 2011.  He helped create HemaCare’s current strategic focus and direction.  He was instrumental in HemaCare’s transition from traditional infusible blood products to its current bioresearch and cell therapy products and services focus.  In his current role, Mr. Juliano heads up HemaCare's global sales and business development within the bioresearch product and cell therapy lines of business.  He leads the company’s sales team and has established its global distribution network.  He also provides executive leadership support throughout the company. 

Mr. Juliano is a seasoned executive with over 25 years of leadership experience within healthcare service companies such as Cardinal Health and Walgreens Infusion and Respiratory Services.  He brings strong operations, sales, Lean Six Sigma, and general management skills to the HemaCare leadership team.

Mr. Juliano received his Bachelor of Science degree in Pharmacy from Purdue University in 1984.  Mr. Juliano completed a Cardinal Health sponsored executive MBA program affiliated with Pepperdine University in 1996.  He is a licensed pharmacist and nuclear pharmacist in New York and Florida. 

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK